Benzhexol

Quick links to important sections

Benzhexol

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benzhexol

What is Benzhexol? An Overview

Here are a few Quick Facts about Benzhexol:

Property Description
Active Ingredient Trihexyphenidyl (INN)
Form Oral tablet
Pharmacological Class Anticholinergic / Antimuscarinic
Common Use Treating Parkinson's symptoms and drug-induced movement disorders
Origin Synthetic (Man-made)

Benzhexol is the common name for the prescription drug known by its International Nonproprietary Name (INN), Trihexyphenidyl. This medication is a synthetic compound, manufactured entirely in a laboratory, and is typically supplied for oral administration in the form of tablets. As an established and efficacious treatment for movement disorders, Trihexyphenidyl is clinically recognized for its essential role in global healthcare and is included on the Model List of Essential Medicines.


What Type of Medicine is Benzhexol and How is it Classified?

Benzhexol is primarily classified as an anticholinergic or antimuscarinic drug. This designation indicates its primary function is to regulate certain nerve signals within the central nervous system. Specifically, the drug acts as a selective M1 muscarinic acetylcholine receptor antagonist. This classification confirms the drug's role in helping to rebalance the nervous system activity that controls motor function.


What is the Main Therapeutic Use of Benzhexol?

The general therapeutic purpose of Benzhexol is the focused management of movement abnormalities resulting from neurochemical imbalances. Its most common application is addressing core motor symptoms of Parkinson's disease, such as muscular rigidity and persistent tremor. Furthermore, it is widely utilized for individuals experiencing drug-induced extrapyramidal side effects (EPS)—unwanted, involuntary movements triggered by other prescribed medications, such as certain antipsychotics. This therapeutic profile highlights its unique ability to counteract movement disorders.

What side effects are possible with Benzhexol?

Possible Side Effects and Safety Information

The safety profile for Benzhexol (Trihexyphenidyl) is primarily characterized by anticholinergic effects and is documented across several physiological systems in official regulatory labeling. These effects typically involve the central nervous, gastrointestinal, and ocular systems.

Official Adverse Reactions and Patterns

The most frequently reported minor side effects, such as dry mouth (xerostomia), blurred vision, dizziness, and nervousness, are often more pronounced at the start of treatment and are noted in regulatory documents to generally diminish or disappear as therapy continues . Gastrointestinal effects, including constipation, nausea, and vomiting, along with urinary retention, are also officially listed as possible occurrences.

Serious Adverse Reactions and Safety Constraints

Official labeling documents specific serious adverse reactions that require adherence to safety constraints:

  • Ocular Risks: The medication can increase intraocular pressure, potentially leading to acute congestive glaucoma. Patients must be monitored for ocular pressure prior to and during treatment.
  • Gastrointestinal Risk: Paralytic ileus (impaired bowel movement) is a documented serious adverse reaction.
  • Mental Status: Psychotic manifestations, including confusion and excitement, are listed, particularly in susceptible populations.
  • Thermoregulation: The drug may impair the body's ability to sweat (anhidrosis), increasing the risk of hyperthermia (heat stroke), necessitating caution in hot environments.

Population-Specific Safety Considerations

Regulatory documents highlight that older adults are more susceptible to experiencing mental confusion and are at greater risk of complications such as glaucoma and urinary retention. Caution is also required in individuals with pre-existing conditions like severe heart disease or obstructive diseases of the urinary or gastrointestinal tracts.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information for Benzhexol

Overdose with Benzhexol (Trihexyphenidyl) is documented in regulatory labeling as manifesting an anticholinergic toxidrome. This presentation is characterized by signs of both central and peripheral nervous system overstimulation and includes severe symptoms such as agitation, confusion, hallucinations, delirium, seizures, and the potential progression to stupor or coma.

Physiological signs often include a dangerously elevated body temperature (hyperpyrexia), tachycardia (fast heart rate), mydriasis (dilated pupils), and dryness of mucous membranes.

Official Regulatory Risk and Action

Overdose Risk Factor Regulator-Documented Severity
Life-Threatening Outcome Progression to circulatory failure, respiratory failure, and death.
High-Risk Circumstances Overdose taken with other CNS-depressant agents or in patients with a compromised respiratory condition.

Regulators emphasize the need to seek emergency medical attention or call the poison control helpline immediately if an overdose is suspected. Urgent medical help is required if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Management focuses on symptomatic and supportive care, including measures like airway maintenance, gastric decontamination, and close monitoring of vital signs and mental status. The use of physostigmine may be considered to reverse severe central effects.

Therapeutic Uses of Benzhexol

What Benzhexol Treats: Main Uses and Benefits

Benzhexol is considered relevant in contexts involving heightened systemic burden and symptoms of increased neurological or muscular activity. It is commonly used to provide symptomatic support for movement disorders.


Easing Core Symptoms of Parkinson's Disease

Benzhexol is commonly used to provide symptomatic support for the motor manifestations of Parkinson's disease, and may assist in addressing muscle rigidity (stiffness) and pronounced resting tremor. It is applied in situations where these symptoms create noticeable interference with daily stability, offering support that may contribute to improved day-to-day comfort and physical ease.

Stabilizing Drug-Induced Involuntary Movements and Secretions

The medication is relevant for addressing extrapyramidal side effects (EPS), which are disruptive, involuntary movement patterns, spasms, or painful contractions caused by other necessary medications. It is applied in clinical settings marked by heightened patient distress from these acute manifestations, playing a role in easing the overall burden of symptoms and may assist with supporting functional stability. It is also considered relevant for easing symptoms related to heightened physiological activity, particularly the challenging issue of sialorrhea (pathological drooling) associated with certain neurological conditions.

Quick Fact: Symptomatic Support
Benzhexol may assist in easing both the resting tremor and the discomfort of muscular rigidity associated with Parkinson's disease, and supports addressing involuntary movements caused by other medications.

Regulatory References

  1. DailyMed - NIH Label for Trihexyphenidyl

Eligibility and Restrictions for Use

Who can and cannot use Benzhexol?

Eligibility for Benzhexol (Trihexyphenidyl) is strictly governed by regulatory classifications which define who may use the medicine and who must not. Use is primarily established for adults requiring symptomatic support for Parkinson's disease or drug-induced movement disorders.

Who Must Not Use Benzhexol (Contraindications):

Classification Population/Condition
Absolute Prohibition Patients with established narrow-angle glaucoma
Absolute Prohibition Individuals with a known hypersensitivity to Trihexyphenidyl

Age and Condition Restrictions:

The medicine is generally not recommended for use in children under 18 years of age due to insufficient data. Older adults require special caution and close observation due to increased sensitivity to anticholinergic effects. Use is restricted and requires close monitoring in patients with pre-existing conditions such as obstructive diseases of the gastrointestinal or genitourinary tracts, as well as patients with renal, hepatic, or cardiovascular disorders. Furthermore, use during pregnancy and lactation is generally not recommended unless specifically deemed necessary by a healthcare provider.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Benzhexol (Trihexyphenidyl) is primarily defined by pharmacodynamic interactions leading to additive effects, as documented in official regulatory labeling.


Documented Interaction Patterns

Interaction Type Interacting Agent(s) Official Description
Additive Anticholinergic Tricyclic Antidepressants, Phenothiazines, MAOIs, Antihistamines, Clozapine Intensification of anticholinergic side effects (e.g., dry mouth, urinary retention).
Additive CNS Depression Alcohol (Ethanol), Opiates, Barbiturates, Cannabinoids Increased sedative effects and potential for central nervous system depression.
Exposure/Efficacy Alteration Levodopa Possible reduction in Levodopa absorption; dosage adjustment of both drugs may be required.
Antagonism Metoclopramide, Domperidone Benzhexol may counteract the effect of gastrointestinal motility agents.

Official labeling also notes specific constraints. Use with other neuroleptics is associated with a risk of developing or worsening tardive dyskinesia. For geriatric patients (over age 60), there is an officially documented increased sensitivity to these additive anticholinergic actions, which carries an enhanced danger of precipitating conditions like acute glaucoma or urinary retention when combined with interacting medications. To minimize minor gastrointestinal discomfort, the tablets are generally better tolerated when taken at mealtimes.

Mechanism of Action

Antagonism of Muscarinic Acetylcholine Receptors

Benzhexol acts as a competitive antagonist primarily by binding to and blocking muscarinic acetylcholine receptors (mAChRs), notably the M1 subtype, within the central nervous system. This molecular interaction prevents the excitatory signaling of the endogenous neurotransmitter acetylcholine (ACh), thereby suppressing a key component of the cholinergic drive in motor pathways.


Modulation of the Striatal Motor Pathway

The central action of the drug occurs in the striatum, a motor control region where it modifies the functional equilibrium between dopamine (DA) and acetylcholine (ACh). By reducing the influence of the overactive cholinergic system, the mechanism alters the resulting neural signal output from the basal ganglia motor circuit.


Central Motor Inhibition and Physiological Consequence

This neurochemical rebalancing leads to an indirect central motor inhibition, which is a direct physiological consequence of modulating the dysregulated neural firing patterns in the motor regulation pathways. This process results in the adjustment of the neural output that governs muscle tone and movement patterns.

Dosage and Administration Information

How to Use Benzhexol: Administration Guidelines

Benzhexol (Trihexyphenidyl) is prescribed for oral administration and is available as tablets (2 mg and 5 mg) and an oral solution (2 mg per 5 mL). The general principle of use involves starting with a low daily dose and gradually increasing the amount over time.


Dosage and Schedule

Instruction Category General Guidelines
Starting & Titration The initial dose is typically 1 mg once daily. The dose is then increased gradually by 2 mg increments every three to five days.
Maintenance Dose The usual total daily dose ranges from 6 mg to 10 mg, though doses up to 15 mg may be necessary for some conditions.
Frequency The total daily dose is best tolerated when divided and taken in three doses at mealtimes. For total daily doses exceeding 10 mg, a fourth dose may be added at bedtime.

Administration Context and Adjustments

General instructions provide guidance on when to administer the medicine relative to food. It may be taken before meals if excessive dry mouth is a major concern, unless doing so causes nausea. Alternatively, administration after meals is preferred for patients experiencing excessive salivation.

Special consideration is given to certain populations and environmental factors. Initial doses should be kept low and increased cautiously for patients over 60 years of age. Additionally, caution is advised in hot weather, as the dose may require reduction to avoid impairing the body's ability to regulate heat.

When discontinuing use, the medication must be withdrawn gradually; abrupt cessation should be avoided to prevent an acute return of symptoms.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Benzhexol (Trihexyphenidyl)


Evidence for Use in Parkinson's Disease Symptoms

Research exploring Benzhexol's evaluation for Parkinson's disease symptoms is largely based on older Randomized Controlled Trials (RCTs) and long-term observational data. These studies were conducted during periods when the medicine was first introduced or prior to the broad availability of other treatment options. Researchers primarily examined how symptoms change over time, specifically monitoring outcomes related to motor function, such as muscular rigidity (stiffness) and pronounced resting tremor.

Findings describe patterns observed in the studies where measured outcomes related to motor function changed. Trials reported patterns related to these specific motor manifestations across the observed populations. However, the evidence is limited by a lack of recent, large-scale RCTs examining this medicine alongside currently available treatment options. Additionally, certainty remains low regarding its effects on all aspects of the condition, such as generalized bradykinesia (slowness of movement), where research exploring short-term symptom changes has yielded mixed findings.


Evidence for Use in Drug-Induced Movement Disorders (EPS)

Benzhexol was studied in research exploring drug-induced extrapyramidal side effects (EPS), which are involuntary movements or spasms caused by other medications. Studies exploring short-term symptom changes primarily monitored outcomes describing episodic or acute changes, such as acute dystonia. Studies focusing on episodes where symptoms become more noticeable reported patterns related to the measured change in acute movement disorders in the observed populations. The medicine was observed in trials assessing short-term or episodic symptom patterns.

Research also describes a specific pattern regarding tardive dyskinesia, a different type of involuntary movement. Studies report that using the medicine was not associated with measurable changes in this condition, and some research has observed patterns related to increased symptom activity during the study period. Evidence is limited and heterogeneous regarding its role in preventing drug-induced movement disorders.


What is Still Uncertain About Benzhexol Research

Research provides limited insight into long-term outcomes across all indications, and long-term effects are not fully established by controlled trials. A primary uncertainty is the lack of recent, large-scale research. Most of the high-certainty data is decades old, and comparative evidence is lacking against currently available treatment options. Studies help show what has been observed so far, but research provides context about group patterns, not personal outcomes, and does not determine whether an individual will respond similarly.

Key Studies & References

  1. Label: TRIHEXYPHENIDYL HYDROCHLORIDE tablet - DailyMed

Frequently Asked Questions (FAQ)

Common questions about Benzhexol (FAQ)


Q: How long does it typically take before Benzhexol starts to affect symptoms?

A: Official documentation describes the onset of action (when the medicine starts to work) following oral administration as typically occurring within one hour. This information is based on data found in official regulatory documents.


Q: How long does the effect of a single dose of Benzhexol usually last?

A: Data from official regulatory documents indicate that the duration of effect from a single dose typically lasts between 6 and 12 hours. This timeframe can vary and may be influenced by the prescribed dosage.


Q: What does the research evidence say about Benzhexol's use in younger patients?

A: Regulatory guidance and official product information state that the medicine is generally not recommended for use in children under 18 years of age. This recommendation is based on a lack of sufficient data and research to establish the medicine's safe use in this population.


Q: Why do some authoritative sources mention a potential for misuse or abuse with Benzhexol?

A: Regulatory documents indicate that the medicine carries a potential for misuse or dependence. This classification is due to the drug’s documented euphoriant properties that may affect mood in some individuals.


Q: Can Benzhexol affect memory or cause confusion in some patients?

A: Yes, regulatory warnings state that Benzhexol may be associated with effects on mental status. Confusion and memory problems are explicitly documented as possible side effects, and these effects may be more pronounced in susceptible populations such as older adults.


Q: Does Benzhexol interact with common medications for depression or anxiety?

A: Official documentation notes interactions with certain classes of medicines used for mood and anxiety disorders, such as tricyclic antidepressants and MAO inhibitors. Official labeling indicates that using Benzhexol alongside these medicines may lead to an increased effect of anticholinergic side effects.


Q: What are the official safety statements regarding using Benzhexol during pregnancy?

A: Official classifications, such as the US FDA Pregnancy Category C, advise caution. Use during pregnancy is generally not recommended unless the medicine is specifically deemed necessary by a prescriber.


Q: Are there any reported instances of Benzhexol being associated with changes in mood or nervousness?

A: Yes, official adverse reaction listings include nervousness, anxiety, agitation, delirium, and euphoria as possible effects. Changes in mood or psychological state are documented and part of the medicine's known safety profile.


Q: Do official sources mention any risk of hallucinations while using Benzhexol?

A: Official adverse reaction documents explicitly list hallucinations as a possible serious side effect. These are noted to sometimes occur alongside other psychotic manifestations or severe mental status changes.


Q: What are the indications that a side effect of Benzhexol might be serious and require attention?

A: Official patient information describes signs of serious adverse reactions to be aware of. These indications include difficulty breathing, acute eye pain, a fast or irregular heartbeat, or sudden severe confusion or agitation. These signs are noted to require prompt medical evaluation.


Q: Are there different forms of Benzhexol available (e.g., tablet, liquid)?

A: Yes, the official prescribing information states that Benzhexol is supplied for oral administration in multiple forms. It is available as both a tablet and as an oral solution.


Q: What kind of monitoring is recommended by doctors while a person is taking Benzhexol?

A: Regulatory guidance specifically recommends monitoring intraocular pressure (eye pressure) due to the documented risk of acute glaucoma. This monitoring is often recommended prior to and during the course of treatment.


Q: Is Benzhexol considered a first-line treatment for movement disorders?

A: The medicine is generally not typically considered a first-line treatment option, especially for older adults. Official geriatric guidance recommends that healthcare providers consider nonanticholinergic agents first when addressing Parkinson's disease symptoms.


Q: Does Benzhexol affect a person's ability to drive or operate machinery?

A: Official warnings state that the medicine may impair the mental and/or physical abilities required for performing hazardous tasks. This includes activities such as operating machinery or driving a motor vehicle.


Q: What does available evidence say about Benzhexol's use alongside Levodopa?

A: Studies and regulatory documents have noted two key findings regarding this combination. First, concomitant use may increase involuntary movements. Second, Benzhexol could delay gastric emptying, potentially decreasing the absorption of Levodopa. Official guidance indicates that dose adjustments for both medicines may be required.


Q: Is Benzhexol a medication that is known to lose effectiveness over time?

A: Official documents note that tolerance, meaning a reduced responsiveness to the effects of the medicine, may develop during therapy. This pattern may require adjustments to the dosage to maintain the desired effect.

How should Benzhexol be stored and disposed of?

How to Store and Dispose of Benzhexol (Trihexyphenidyl Hydrochloride)

This medicine must be stored strictly according to the conditions defined in official regulatory labeling to maintain stability.

Storage Category Official Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Keep in a tight, light-resistant container, away from excess heat and moisture (e.g., not the bathroom).
Child Safety Mandatory to store the medication out of the sight and reach of children.

Disposal must align with all local and federal regulations. Unused or expired tablets should be managed through drug take-back programs when available. If a take-back program is not accessible, the FDA advises mixing the medication with an undesirable substance (like coffee grounds or dirt) before sealing and placing it in the household trash, ensuring all personal information is removed from the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Benzhexol found in:

A-Z Index: